Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $101.55 USD
Change Today +1.21 / 1.21%
Volume 6.1M
JNJ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
Sao Paulo
Bogota
As of 8:04 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

johnson & johnson (JNJ) Snapshot

Open
$101.24
Previous Close
$100.34
Day High
$101.86
Day Low
$100.76
52 Week High
11/13/14 - $109.49
52 Week Low
10/15/14 - $95.10
Market Cap
282.4B
Average Volume 10 Days
8.4M
EPS TTM
$5.97
Shares Outstanding
2.8B
EX-Date
02/20/15
P/E TM
17.0x
Dividend
$2.80
Dividend Yield
2.76%
Current Stock Chart for JOHNSON & JOHNSON (JNJ)

johnson & johnson (JNJ) Details

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages and first aid products under the BAND-AID and NEOSPORIN brand names; and nutritional products comprising no calorie sweetener under the SPLENDA brand name. This segment also offers over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic, and trauma and neurological products; general surgery, and biosurgical and energy products; products to treat cardiovascular disease; infection prevention products; diagnostics products; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company distributes its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

126,500 Employees
Last Reported Date: 02/24/15
Founded in 1885

johnson & johnson (JNJ) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: $1.5M
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $878.1K
Chief Scientific Officer, Worldwide Chairman ...
Total Annual Compensation: $1.1M
Group Worldwide Chairman and Member of Execut...
Total Annual Compensation: $841.3K
Vice President, General Counsel and Member of...
Total Annual Compensation: $591.3K
Compensation as of Fiscal Year 2014.

johnson & johnson (JNJ) Key Developments

Johnson & Johnson Announces Plans to Collaborate with Google on Surgical Robotics

Johnson & Johnson announced plans to collaborate with Google on surgical robotics. The two companies announced in a statement they would work to create an innovative robotic-assisted surgical platform capable of integrating advanced technologies with the goal of improving health care delivery in the operating room. The firms announced they would seek to improve techniques for robotic-assisted surgery -- a minimally invasive procedure that uses technology to give surgeons greater control, access and accuracy.

Johnson & Johnson Unit Agrees to Pay $20 million to Settle U.S. Lawsuit over Tainted Tylenol, Motrin

Johnson & Johnson unit pleaded guilty to violating the federal Food, Drug and Cosmetic Act with regard to infants' and children's liquid medications, agreeing to pay a criminal fine of $20 million and forfeit $5 million. The agreement settles a U.S. government probe into a Pennsylvania plant that recalled Tylenol and other over-the-counter medicines several years ago because of quality lapses. McNeil's Fort Washington, Pennsylvania plant remains closed under a 2011 permanent injunction.

Johnson & Johnson Seeks Acquisitions

Johnson & Johnson (NYSE:JNJ) is looking for acquisition opportunities. Johnson & Johnson has already started to bolster its pipeline with acquisitions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $101.55 USD +1.21

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $25.12 USD +0.26
International Business Machines Corp $162.67 USD +2.27
Novartis AG SFr.97.85 CHF +1.65
Pfizer Inc $35.00 USD +0.47
Roche Holding AG SFr.265.00 CHF +1.80
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 17.6x
Price/Sales 3.8x
Price/Book 4.0x
Price/Cash Flow 17.1x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.